Clovis Oncology (NASDAQ:CLVS) will release its earnings data before the market opens on Thursday, August 1st. Analysts expect Clovis Oncology to post earnings of ($1.70) per share for the quarter. Clovis Oncology (NASDAQ:CLVS) last issued its earnings results on Tuesday, May 7th. The biopharmaceutical company reported ($1.63) earnings per share …
Read More »
Clovis Oncology (NASDAQ:CLVS)’s stock price hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $10.60 and last traded at $10.69, with a volume of 3245 shares traded. The stock had previously closed at $11.07. Several brokerages have issued reports on CLVS. SunTrust …
Read More »
HC Wainwright reaffirmed their buy rating on shares of Clovis Oncology (NASDAQ:CLVS) in a research report released on Wednesday, July 3rd, Stock Target Advisor reports. “Our $36 price target is derived from a sum-of-the-parts analysis based on probability-adjusted revenue forecasts for Rubraca in ovarian cancer combination and prostate cancer indications, …
Read More »
Clovis Oncology (NASDAQ:CLVS)’s stock price dropped 5.9% on Friday . The stock traded as low as $11.23 and last traded at $10.89, approximately 85,920 shares were traded during mid-day trading. A decline of 96% from the average daily volume of 2,020,116 shares. The stock had previously closed at $11.57. A …
Read More »
Clovis Oncology (NASDAQ:CLVS) shares hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $11.34 and last traded at $11.34, with a volume of 1732319 shares trading hands. The stock had previously closed at $12.33. Several equities analysts recently issued reports on the …
Read More »